Market Cap

$44.0M

Volume

541.5K

Cash and Equivalents

$37.3M

EBITDA

-$73.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

N/A

Profit Margin

N/A

52 Week High

$11.32

52 Week Low

$0.82

Dividend

N/A

Price / Book Value

0.65

Price / Earnings

-0.59

Price / Tangible Book Value

0.65

Enterprise Value

-$32.9M

Enterprise Value / EBITDA

0.45

Operating Income

-$73.8M

Return on Equity

97.04%

Return on Assets

-52.19

Cash and Short Term Investments

$77.3M

Debt

$456.0K

Equity

$67.5M

Revenue

N/A

Unlevered FCF

-$43.0M

Sector

Pharmaceuticals

Category

N/A